CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total	Stockholders’ Equity	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive (Loss)	Treasury stock, at cost	Non-controlling interest
Balance at Dec. 31, 2022	$ 103,864	$ 100,017	$ 12	$ 787,130	$ (688,492)	$ 1,371	$ (4)	$ 3,847
Balance (in Shares) at Dec. 31, 2022			106,417,265
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of RSUs
Vesting of RSUs (in Shares)			2,547,619
Issuance of RSAs
Issuance of RSAs (in Shares)			458,755
Exercise of common stock options	73	73		73
Exercise of common stock options (in Shares)			260,228
Exercise of common warrants	882	882		882
Exercise of common warrants (in Shares)			408,231
Stock-based compensation expense	20,207	20,207		20,207
Issuance of common warrants	22,843	22,843		22,843
Interest payment through issuance of shares of common stock	1,888	1,888		1,888
Interest payment through issuance of shares of common stock (in Shares)			448,466
Redemption of non-controlling interests	660	3,145		3,145				(2,485)
Redemption of non-controlling interests (in Shares)			719,693
Reclassification of warrant liability to common stock warrants	1,248	1,248		1,248
Shares of Common Stock received from settlement of employee receivables	(661)	(661)					(661)
Shares of Common Stock received from settlement of employee receivables (in Shares)			(128,035)
Net loss	(71,735)	(71,735)			(71,735)
Foreign currency translation adjustment	827	827				827
Balance at Dec. 31, 2023	80,096	78,734	$ 12	837,416	(760,227)	2,198	(665)	1,362
Balance (in Shares) at Dec. 31, 2023			111,132,222
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of RSUs	1	1	$ 1
Vesting of RSUs (in Shares)			2,456,403
Issuance of RSAs
Issuance of RSAs (in Shares)			269,453
Exercise of common stock options	3,787	3,787		3,787
Exercise of common stock options (in Shares)			1,381,143
Exercise of common warrants	31,387	31,387	$ 1	31,386
Exercise of common warrants (in Shares)			14,531,193
Stock-based compensation expense	14,040	14,040		14,040
Interest payment through issuance of shares of common stock	3,842	3,842		3,842
Interest payment through issuance of shares of common stock (in Shares)			352,171
Redemption of non-controlling interests	67	1,429		1,429				(1,362)
Redemption of non-controlling interests (in Shares)			397,037
Reclassification of warrant liability to common stock warrants	11,523	11,523		11,523
Shares of Common Stock received from settlement of employee receivables	(28)	(28)					(28)
Shares of Common Stock received from settlement of employee receivables (in Shares)			(3,016)
Shares of Common Stock issued to settle Asset Purchase Agreement liability	8,818	8,818		8,818
Shares of Common Stock issued to settle Asset Purchase Agreement liability (in Shares)			620,106
Net loss	(101,879)	(101,879)			(101,879)
Foreign currency translation adjustment	(1,533)	(1,533)				(1,533)
Balance at Dec. 31, 2024	$ 50,121	$ 50,121	$ 14	$ 912,241	$ (862,106)	$ 665	$ (693)
Balance (in Shares) at Dec. 31, 2024			131,136,712